ORLANDO, G, LAW, P.J, PALIN, K, TUUPANEN, S, GYLFE, A, HÄNNINEN, U.A, CAJUSO, T, TANSKANEN, T, KONDELIN, J, KAASINEN, E, SARIN, A-P, KAPRIO, J, ERIKSSON, J.G, RISSANEN, H, KNEKT, P, PUKKALA, E, JOUSILAHTI, P, SALOMAA, V, RIPATTI, S, PALOTIE, A, JÄRVINEN, H, RENKONEN-SINISALO, L, LEPISTÖ, A, BÖHM, J, MECKLIN, J-P, AL-TASSAN, N.A, PALLES, C, MARTIN, L, BARCLAY, E, TENESA, A, FARRINGTON, S, TIMOFEEVA, M.N, MEYER, B.F, WAKIL, S.M, CAMPBELL, H, SMITH, C.G, IDZIASZCZYK, S, MAUGHAN, T.S, KAPLAN, R, KERR, R, KERR, D, BUCHANAN, D.D, WIN, A.K, HOPPER, J, JENKINS, M, LINDOR, N.M, POLLY A. NEWCOMB,, GALLINGER, S, CONTI, D, SCHUMACHER, F, CASEY, G, TAIPALE, J, CHEADLE, J.P, DUNLOP, M.G, TOMLINSON, I.P, AALTONEN, L.A and HOULSTON, R.S.
(2016)
Variation at 2q35 (PNKD and TMBIM1) influences colorectal cancer risk and identifies a pleiotropic effect with inflammatory bowel disease.
Human Molecular Genetics, 25(11), 2349-2359.